Dr. Andreas Laupacis, President/CEO of the Institute for Clinical Evaluative Services and Professor of Medicine at the University of Toronto, describes the Canadian drug system and the rationale behind it, provides a summary of the perspectives of the different groups involved in the system (i.e., patients, physicians, pharmaceutical industry) and offers suggestions for improvement.

Approx. 16 minutes
19 slides
Date: 2006/01
Location: Montreal, Quebec